Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis
- PMID: 22935632
Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis
Abstract
Objectives: The present paper aims at identifying the predictors of end-stage renal disease (ESRD) and at determining the long-term outcome of ESRD patients according to renal replacement modality in Korean patients with lupus nephritis (LN).
Methods: Between 1985 and 2010, 321 Korean patients with LN were enrolled in this study. We analysed the clinical and laboratory indices, the treatment responses and the biopsy findings. The events of interest were estimated by the Kaplan-Meier method and the risk factors were assessed by univariate and multivariate Cox proportional hazards regression analyses.
Results: The median follow-up time after the diagnosis of LN was 84 months. During follow-up, twenty-nine patients evolved to ESRD. Renal survival rate at 5 and 10 years after LN onset was 95.9% and 91.1%, respectively. Deteriorated renal function (estimated glomerular filtration rate <60 ml/min/1.73m2) at LN onset (hazard ratio: 9.223) was found to be an independent risk factor for the development of ESRD. Recurrence of lupus nephritis in renal allograft and flare-ups of lupus activity were not observed among the patients undergoing kidney transplantation (KT) (n=11). In contrast, those with maintenance dialysis (n=18) developed 13 episodes of lupus flare in 10 patients and 5 died of either infection (n=2) or lupus flare (n=3).
Conclusions: The impaired renal function at baseline is an independent predictor of ESRD in Korean patients with LN. The benefits of KT on the control of lupus activity and survival should be emphasised.
Similar articles
-
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.Lupus. 2016 Apr;25(5):547-57. doi: 10.1177/0961203315619031. Epub 2015 Dec 3. Lupus. 2016. PMID: 26637291
-
Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.Lupus. 2016 Jan;25(1):3-11. doi: 10.1177/0961203315595130. Epub 2015 Jul 8. Lupus. 2016. PMID: 26159540
-
Long-term outcome of biopsy-proven lupus nephritis in Iran.Int J Rheum Dis. 2013 Dec;16(6):739-46. doi: 10.1111/1756-185X.12228. Epub 2013 Nov 25. Int J Rheum Dis. 2013. PMID: 24267776
-
Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.BMC Nephrol. 2020 May 1;21(1):156. doi: 10.1186/s12882-020-01811-y. BMC Nephrol. 2020. PMID: 32357924 Free PMC article.
-
Lupus nephritis and end-stage kidney disease.Am J Med Sci. 2013 Oct;346(4):319-23. doi: 10.1097/MAJ.0b013e31827f4ee3. Am J Med Sci. 2013. PMID: 23370533 Review.
Cited by
-
Long-term renal outcomes of systemic lupus erythematosus in a Taiwanese population: a single-center retrospective study.Clin Rheumatol. 2025 Sep 2. doi: 10.1007/s10067-025-07618-2. Online ahead of print. Clin Rheumatol. 2025. PMID: 40892301
-
Metformin Suppresses Systemic Autoimmunity in Roquinsan/san Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3.J Immunol. 2017 Apr 1;198(7):2661-2670. doi: 10.4049/jimmunol.1403088. Epub 2017 Feb 27. J Immunol. 2017. PMID: 28242651 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical